864 Close Monitoring of CRP and Fecal Calprotectin is Able to Predict Clinical Relapse in Patients With Crohn's Disease in Remission After Infliximab Withdrawal. a Sub-Analysis of the Stori Study

✍ Scribed by Nicolas de Suray; Julia Salleron; Gwenola Vernier-Massouille; Jean-Charles Grimaud; Yoram Bouhnik; David Laharie; Jean-Louis Dupas; Hélène Pillant-Le Moult; Laurence Picon; Michel Veyrac; Mathurin Flamant; Guillaume Savoye; Raymond Jian; Martine De Vos; Eric Piver; Jean-Frederic Colombel; Edouard Louis

• Book ID: 119433403
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 68 KB
• Volume: 142
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/s0016-5085(12)60560-5